Astec Lifesciences will hold a meeting of the Board of Directors of the Company on 29 July 2024.Powered by Capital Market - Live News

Astec Lifesciences announced that the Annual General Meeting(AGM) of the company will be held on 29 July 2024.Powered by Capital Market - Live News

Net Loss of Astec Lifesciences reported to Rs 0.97 crore in the quarter ended March 2024 as against net loss of Rs 4.98 crore during the previous quarter ended March 2023. Sales rose 21.09% to Rs 153.75 crore in the quarter ended March 2024 as against Rs 126.97 crore during the previous quarter ended March 2023.For the full year,net loss reported to Rs 46.93 crore in the year ended March 2024 as against net profit of Rs 25.56 crore during the previous year ended March 2023. Sales declined 27.06% to Rs 458.18 crore in the year ended March 2024 as against Rs 628.17 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales153.75126.97 21 458.18628.17 -27 OPM %8.274.26 --1.2912.14 - PBDT8.081.58 411 -25.4968.60 PL PBT-0.93-6.18 85 -61.7534.95 PL NP-0.97-4.98 81 -46.9325.56 PL Powered by Capital Market - Live News

Astec Lifesciences will hold a meeting of the Board of Directors of the Company on 2 May 2024.Powered by Capital Market - Live News

Net loss of Astec Lifesciences reported to Rs 24.33 crore in the quarter ended December 2023 as against net profit of Rs 0.84 crore during the previous quarter ended December 2022. Sales declined 56.66% to Rs 50.79 crore in the quarter ended December 2023 as against Rs 117.18 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales50.79117.18 -57 OPM %-36.0910.34 - PBDT-23.5210.04 PL PBT-32.221.24 PL NP-24.330.84 PL Powered by Capital Market - Live News